Marksans Pharma Ltd - Share Price
MARKSANS
Marksans Pharma LtdFinancials
Marksans Pharma LtdNews & Updates
Marksans Pharma freezes at upper circuit on voluntary expanding Metformin Hydrochloride tablets reca
Oct 05,2020 03:57 PM
The tablets are indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes melli
Marksans Pharma zooms 5% as consolidated Q1 PAT rises by 119.6% yoy to Rs49.4cr Aug 04,2020
Marksans Pharma recalls one batch of Metformin Extended Release tablets 500 Mg due to NDMA detection Jun 08,2020
Marksan Pharma soars 5% on positive credit rating Apr 23,2020
Marksans Pharma gets EIR from USFDA for New York unit; stock up 5% Feb 11,2020
Marksans Pharma gets EIR from USFDA; stock ends 4% higher Jun 06,2019
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 666.80 | 71.74 | 159,903.68 | 327.39 | 1.13 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,288.75 | 58.23 | 113,826.29 | 487.93 | 0.47 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,308.35 | 40.38 | 88,282.36 | 311.50 | 0.47 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 955.85 | 31.22 | 77,072.54 | 413.41 | 0.52 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 630.05 | 39.57 | 64,485.55 | 464.70 | 0.56 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Marksans Pharma LtdSummary & Reports
No Company Summary found
Registered Office
11th Flr GRANDEUR Oshiwara,Veera Desai Extn Rd Andheri(W),Mumbai, Maharashtra,400053
Tell. : +91-22-40012000
Website : http://www.marksanspharma.com
Email : companysecretary@marksanspharma.com
Registrar Office
1st Flr Bharat Tin W, Andheri (East), Mumbai - 400059 INDIA
Tell. : +91-22-62638200
Website : www.bigshareonline.com
Email : investor@bigshareonline.com
Reports by marksans-pharma-ltd-share-price
Latest Release by marksans-pharma-ltd-share-price
Result Express
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 48.25% |
| Total Promoter | 48.25% |
| Non Promoter | - |
| Institutions | 4.68% |
| Non-Institutions | 47.07% |
| Total Non-Promoter | 51.75% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
15 Jun 2021
Annc. Date
10 Jun 2021
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sc... More
Purpose
Board Meeting
Exp. Date
31 May 2021
Annc. Date
24 May 2021
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sc... More
Purpose
Board Meeting
Exp. Date
08 Feb 2021
Annc. Date
28 Jan 2021
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sc... More
